Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant vs. Progression-Triggered Treatment With Gemcitabine After Radical Cystectomy for Locally Advanced Transitional Cell Carcinoma of the Bladder in Patients Not Suitable for Cisplatin-Based Chemotherapy - A Phase 3 Study

NCT00146276 is registered in ClinicalTrials.gov with Association of Urologic Oncology (AUO) as lead sponsor.

NCT NCT00146276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00146276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant vs. Progression-Triggered Treatment With Gemcitabine After Radical Cystectomy for Locally Advanced Transitional Cell Carcinoma of the Bladder in Patients Not Suitable for Cisplatin-Based Chemotherapy - A Phase 3 Study
Lead sponsor
Association of Urologic Oncology (AUO)
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2000
Completion date
Not reported
Enrollment
178
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, carcinoma, transitional cell